R&D Systems Inc. Tocris Bioscience Boston Biochem

MET Receptor

More Information »The MET receptor, also known as hepatocyte growth factor receptor (HGFR), is a proto-oncogenic receptor tyrosine kinase. The endogenous ligand for MET is hepatocyte growth factor/scatter factor (HGF), a disulfide-linked heterodimeric molecule.

MET Receptor Products

Product Name / Activity
1683 K 252a
Receptor tyrosine kinase inhibitor, inhibits MET
5369 Norleual
Highly potent HGF/c-MET inhibitor; also AT4 antagonist
4239 PF 04217903 mesylate
Highly selective c-Met inhibitor
2693 PHA 665752
Potent and selective MET inhibitor
4101 SU 11274
Selective inhibitor of MET kinase activity
3037 SU 5416
MET inhibitor. Also inhibits KIT, RET, VEGFR and FLT3
5422 XL 184
Potent c-MET inhibitor; also inhibits other RTKs
Related Categories

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

Kinases Product Listing

Kinases Product Listing

Highlights over 400 products for kinase research. Request a copy or view PDF today.

divider line

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Kinase Inhibitor Toolbox

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.

divider line

New Product Guide


Highlights 150 new products added in the second half of 2014. View PDF today.

divider line

Twitter Updates

Follow @Tocris on Twitter

Follow us on Twitter!

Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.